Mitchell Levine

Mitchell Levine

Chairman bij IMMUNOPRECISE ANTIBODIES LTD.

Vermogen: 30 400 $ op 31-03-2024

Finance
Health Technology
Consumer Services

Profiel

Mitchell Stuart Levine is the founder of Enable Global Capital LLC, which was founded in 2002.
He held the title of Managing Member & Chief Compliance Officer at Enable Global Capital LLC from 2011 to 2017.
Mr. Levine is currently the Chairman & Chief Executive Officer at Smart Health Diagnostics Co. since 2022 and the Chairman at ImmunoPrecise Antibodies Ltd.
since 2023.
Mr. Levine has held former positions as Principal at Bear, Stearns & Co., Inc., Principal at Lehman Brothers Distressed Structured Credit Capital Partners, Principal at The Shemano Group, Inc., Managing Partner at Cove Capital Advisors, Inc., and Chief Financial Officer at OncoCyte Corp.
from 2017 to 2022.
Mr. Levine obtained his undergraduate degree from the University of California, Davis.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
21-03-2024 20 000 ( 0.08% ) 30 400 $ 31-03-2024

Actieve functies van Mitchell Levine

BedrijvenFunctieBegin
IMMUNOPRECISE ANTIBODIES LTD. Chairman 27-11-2023
Chief Executive Officer 01-11-2022
Alle actieve functies van Mitchell Levine

Eerdere bekende functies van Mitchell Levine

BedrijvenFunctieEinde
Founder 01-01-2017
Cove Capital Advisors, Inc. Corporate Officer/Principal -
ONCOCYTE CORPORATION Director of Finance/CFO 01-06-2022
Lehman Brothers Distressed Structured Credit Capital Partners Corporate Officer/Principal -
Corporate Officer/Principal -
Ervaring van Mitchell Levine in detail bekijken

Opleiding van Mitchell Levine

University of California, Davis Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Mitchell Levine in detail bekijken

Connecties

18

Eerstegraads connecties

9

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven2
ONCOCYTE CORPORATION

Health Technology

IMMUNOPRECISE ANTIBODIES LTD.

Health Technology

Bedrijven in privébezit6

Finance

Lehman Brothers Distressed Structured Credit Capital Partners

Finance

Finance

Cove Capital Advisors, Inc.

Health Technology

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Mitchell Levine